Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes

BACKGROUND: Determining the driving factors and molecular flow-through that define the switch from favorable to aggressive high-risk disease is critical to the betterment of neuroblastoma cure. METHODS: In this study, we examined the cytogenetic and tumorigenic physiognomies of distinct population o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Khan, Faizan H., Pandian, Vijayabaskar, Ramraj, Satishkumar, Natarajan, Mohan, Aravindan, Sheeja, Herman, Terence S., Aravindan, Natarajan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496850/
https://ncbi.nlm.nih.gov/pubmed/26159519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1463-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars